Forte Biosciences, Inc. (FBRX)
FBRX Stock Price Chart
Explore Forte Biosciences, Inc. interactive price chart. Choose custom timeframes to analyze FBRX price movements and trends.
FBRX Company Profile
Discover essential business fundamentals and corporate details for Forte Biosciences, Inc. (FBRX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 Apr 2017
Employees
14.00
Website
https://www.fortebiorx.comCEO
Paul A. Wagner
Description
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
FBRX Financial Timeline
Browse a chronological timeline of Forte Biosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 Aug 2026
EPS estimate is -$1.03.
Earnings released on 11 May 2026
EPS came in at -$1.24 falling short of the estimated -$1.16 by -6.90%.
Earnings released on 31 Mar 2026
EPS came in at -$1.45 falling short of the estimated -$1.42 by -2.11%.
Earnings released on 14 Nov 2025
EPS came in at -$0.99 surpassing the estimated -$1.04 by +4.81%.
Earnings released on 14 Aug 2025
EPS came in at -$0.96 surpassing the estimated -$1.21 by +20.66%.
Earnings released on 15 May 2025
EPS came in at -$1.37 falling short of the estimated -$0.89 by -53.93%.
Earnings released on 24 Mar 2025
EPS came in at -$2.45 surpassing the estimated -$4.55 by +46.15%.
Earnings released on 14 Nov 2024
EPS came in at -$4.54 surpassing the estimated -$6.75 by +32.74%.
Stock split effective on 28 Aug 2024
Shares were split 1 : 25 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Aug 2024
EPS came in at -$6.75 falling short of the estimated -$4.00 by -68.75%.
Earnings released on 13 May 2024
EPS came in at -$4.00 falling short of the estimated -$0.16 by -2.40k%.
Earnings released on 18 Mar 2024
EPS came in at -$1.00 falling short of the estimated -$0.28 by -257.14%, while revenue for the quarter reached $6.00k .
Earnings released on 13 Nov 2023
EPS came in at -$6.50 surpassing the estimated -$14.25 by +54.39%.
Earnings released on 14 Aug 2023
EPS came in at -$10.50 .
Earnings released on 15 May 2023
EPS came in at -$8.00 .
Earnings released on 31 Mar 2023
EPS came in at -$6.00 falling short of the estimated -$0.16 by -3.65k%.
Earnings released on 14 Nov 2022
EPS came in at -$4.50 falling short of the estimated -$0.15 by -2.90k%.
Earnings released on 15 Aug 2022
EPS came in at -$5.25 falling short of the estimated -$0.17 by -2.99k%.
Earnings released on 16 May 2022
EPS came in at -$4.25 falling short of the estimated -$0.17 by -2.40k%.
Earnings released on 31 Mar 2022
EPS came in at -$5.25 falling short of the estimated -$0.07 by -7.40k%.
Earnings released on 8 Nov 2021
EPS came in at -$13.50 falling short of the estimated -$7.25 by -86.21%.
Earnings released on 16 Aug 2021
EPS came in at -$10.75 falling short of the estimated -$10.00 by -7.50%.
FBRX Stock Performance
Access detailed FBRX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
